These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6292360)

  • 21. Polymerized albumin binding to serum in various liver diseases: its significance and relation to hepatitis B virus infection.
    Dash S; Panda SK; Nayak NC
    J Gastroenterol Hepatol; 1990; 5(1):16-24. PubMed ID: 2103380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum binding activity for polymerized human albumin due to antibodies detected by enzyme-linked immunosorbent assay in acute and chronic type B, A and NANB viral hepatitis.
    Baraldini M; Miglio F; Cursaro C; Stefanini GF; Micaletti E; Pontisso P; Alberti A; Gasbarrini G
    Ric Clin Lab; 1987; 17(2):131-42. PubMed ID: 3114866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Binding activity of circulating HBsAg particles for polymerized human albumin in acute hepatitis B].
    Hopf U; Möller B; Muirhead B; Alexander M
    Z Gastroenterol; 1985 Nov; 23(11):643-9. PubMed ID: 3004050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding activity of HBsAg particles from chronic HBsAg carriers to polystyrene beads coated with polymerized human serum albumin: diagnostic relevance of the assay.
    Hopf U; Möller B; Schermer M; Lobeck H
    Liver; 1984 Dec; 4(6):372-8. PubMed ID: 6394944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers.
    Lieberman HM; LaBrecque DR; Kew MC; Hadziyannis SJ; Shafritz DA
    Hepatology; 1983; 3(3):285-91. PubMed ID: 6301965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency of hepatitis B virus DNA in anti-HBe positive sera on longitudinal follow-up of patients with renal transplants and chronic hepatitis B.
    Norder H; Brattström C; Magnius L
    J Med Virol; 1989 Apr; 27(4):322-8. PubMed ID: 2656911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B e-antigen titres for evaluating infectivity during hepatitis B virus infection.
    Lindenschmidt EG; Granato CF; Salefsky C; Laufs R; Henning H
    Klin Wochenschr; 1984 Mar; 62(5):231-7. PubMed ID: 6716909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An antibody which precipitates Dane particles in acute hepatitis type B: relation to receptor sites which bind polymerized human serum albumin on virus particles.
    Alberti A; Pontisso P; Schiavon E; Realdi G
    Hepatology; 1984; 4(2):220-6. PubMed ID: 6200418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postpartum subsidence of hepatitis B viral replication in HBeAg-positive carrier mothers.
    Lin HH; Chen PJ; Chen DS; Sung JL; Yang KH; Young YC; Liou YS; Chen YP; Lee TY
    J Med Virol; 1989 Sep; 29(1):1-6. PubMed ID: 2584955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
    Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus DNA in asymptomatic HBsAg carriers: comparison with HBeAg/anti-HBe status.
    Berris B; Sampliner RE; Sooknanan R; Feinman SV
    J Med Virol; 1987 Nov; 23(3):233-9. PubMed ID: 3430143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigations of HBe antigen. Note I. Prevalence of HBeAg and anti-HBe in the stationary phase of HBsAg-positive acute viral hepatitis.
    Babeş VT; Tănase M; Cepănaru S; Cepănaru R
    Virologie; 1981; 32(2):93-8. PubMed ID: 6787796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HBeAg and Anti-HBe in various groups of acute hepatitis patients and carriers of HBsAg].
    Zanetti AR
    Boll Ist Sieroter Milan; 1977 Mar; 56(1):74-8. PubMed ID: 861075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B infection in pediatric dialysis and transplant patients: significance of e antigen.
    Ettenger RB; Tong MJ; Landing BH; Mosley J; Malekzadeh MH; Pennisi AJ; Uittenbogaart CH; Jordan SC; Wright H; Fine RN
    J Pediatr; 1980 Oct; 97(4):550-3. PubMed ID: 6999141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virus receptors for polymerized human serum albumin and anti-receptor antibody in hepatitis B virus infection.
    Alberti A; Pontisso P; Chemello L; Schiavon E; Realdi G
    Prog Clin Biol Res; 1983; 143():327-36. PubMed ID: 6322199
    [No Abstract]   [Full Text] [Related]  

  • 37. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
    Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
    Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
    Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A
    Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Markers of viral replication (HBeAg and DNA polymerase activity) in chronic uremia, HBsAg positive, hemodialysis patients].
    Dentico P; Buongiorno R; Angarano G; Monno L; Coppola S; Laddago V; Spinelli A; Pastore G
    Boll Soc Ital Biol Sper; 1980 Nov; 56(21):2193-9. PubMed ID: 7213481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of hepatitis B e antigen for a long period after the clearance of hepatitis B surface antigen.
    Tamura I; Shimase K; Ichimura H; Kurimura O; Kaneto E; Tsuchie H; Kurimura T
    Acta Virol; 1985 Dec; 29(6):505-8. PubMed ID: 2869663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.